Total Payments
$31,849
2023 Payments
$18.26
Companies
17
Transactions
98
Medicare Patients
99
Medicare Billing
$30,931
Payment Breakdown by Category
Other$25,800 (81.0%)
Consulting$2,245 (7.0%)
Food & Beverage$2,015 (6.3%)
Travel$1,250 (3.9%)
Research$500.00 (1.6%)
Education$40.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,800 | 16 | 81.0% |
| Consulting Fee | $2,245 | 1 | 7.0% |
| Food and Beverage | $2,015 | 69 | 6.3% |
| Travel and Lodging | $1,250 | 10 | 3.9% |
| Unspecified | $500.00 | 1 | 1.6% |
| Education | $40.00 | 1 | 0.1% |
Payments by Type
General
$31,349
97 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $27,038 | 39 | $0 (2021) |
| Indivior Inc. | $3,984 | 21 | $0 (2022) |
| Gilead Sciences, Inc. | $125.18 | 6 | $0 (2019) |
| Titan Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| Allergan, Inc. | $92.08 | 5 | $0 (2020) |
| Orexo US, Inc. | $91.64 | 6 | $0 (2019) |
| Boston Scientific Corporation | $87.21 | 1 | $0 (2019) |
| US WorldMeds, LLC | $71.14 | 3 | $0 (2019) |
| Shire North American Group Inc | $60.07 | 3 | $0 (2019) |
| Kaleo, Inc. | $51.38 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.26 | 1 | Braeburn Inc. ($18.26) |
| 2022 | $21.90 | 1 | Indivior Inc. ($21.90) |
| 2021 | $847.31 | 3 | Alkermes, Inc. ($847.31) |
| 2020 | $4,147 | 8 | Alkermes, Inc. ($4,066) |
| 2019 | $11,657 | 36 | Alkermes, Inc. ($11,164) |
| 2018 | $10,601 | 32 | Alkermes, Inc. ($6,575) |
| 2017 | $4,558 | 17 | Alkermes, Inc. ($4,386) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Opioid Use Disorder | ||||||
| 06/12/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: OUD | ||||||
| 11/01/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: CNS | ||||||
| 08/08/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: CNS | ||||||
| 07/02/2021 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: CNS | ||||||
| 12/01/2020 | Alkermes, Inc. | Buprenorphine (Drug), VIVITROL | — | Cash or cash equivalent | $500.00 | Research |
| Study: Survey of Self-reported Cognitive and Other Functioning in Subjects on Buprenorphine or XR-Naltrexone Treatment for Opioid Use Disorder • Category: CNS | ||||||
| 11/26/2020 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CNS | ||||||
| 11/24/2020 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CNS | ||||||
| 09/03/2020 | Allergan, Inc. | VIIBRYD (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: CNS | ||||||
| 02/19/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: OUD | ||||||
| 02/13/2020 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: CNS | ||||||
| 02/01/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: OUD | ||||||
| 11/13/2019 | Boston Scientific Corporation | GENERAL MALE SUI (Device) | Food and Beverage | In-kind items and services | $87.21 | General |
| Category: MALE SUI | ||||||
| 11/12/2019 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CNS | ||||||
| 11/12/2019 | Alkermes, Inc. | VIVITROL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: CNS | ||||||
| 11/11/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $172.84 | General |
| Category: CNS | ||||||
| 11/11/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $54.00 | General |
| Category: CNS | ||||||
| 11/07/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 11/07/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $110.20 | General |
| Category: CNS | ||||||
| 11/07/2019 | Alkermes, Inc. | VIVITROL (Drug) | Travel and Lodging | In-kind items and services | $10.00 | General |
| Category: CNS | ||||||
| 11/05/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: CNS | ||||||
| 10/23/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Survey of Self-reported Cognitive and Other Functioning in Subjects on Buprenorphine or XR-Naltrexone Treatment for Opioid Use Disorder | Alkermes, Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 28 | 112 | $32,320 | $15,992 |
| 2021 | 4 | 71 | 119 | $27,775 | $14,939 |
Total Patients
99
Total Services
231
Medicare Billing
$30,931
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 86 | $17,317 | $8,588 | 49.6% |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2022 | 13 | 26 | $15,004 | $7,404 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 52 | $11,257 | $5,654 | 50.2% |
| G2086 | Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month | Office | 2021 | 15 | 15 | $8,936 | $4,981 | 55.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $7,040 | $3,762 | 53.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 20 | 32 | $542.08 | $542.08 | 100.0% |
About Dr. Marla Kushner, DO
Dr. Marla Kushner, DO is a Family Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538119268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marla Kushner, DO has received a total of $31,849 in payments from pharmaceutical and medical device companies, with $18.26 received in 2023. These payments were reported across 98 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,800).
As a Medicare-enrolled provider, Kushner has provided services to 99 Medicare beneficiaries, totaling 231 services with total Medicare billing of $30,931. Data is available for 2 years (2021–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Chicago, IL
- Active Since 05/11/2006
- Last Updated 12/17/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538119268
Products in Payments
- VIVITROL (Drug) $12,011
- Vivitrol 380 mg (Drug) $10,961
- SUBLOCADE (Drug) $3,598
- Vivitrol (Drug) $3,566
- Buprenorphine (Drug) $500.00
- SUBOXONE SUBLINGUAL FILM (Drug) $385.45
- Probuphine (Drug) $145.88
- Zubsolv (Drug) $91.64
- GENERAL MALE SUI (Device) $87.21
- Lucemyra/Lofexidine (Drug) $71.14
- VYVANSE (Drug) $60.07
- Evzio (Drug) $51.38
- VIIBRYD (Drug) $40.00
- VRAYLAR (Drug) $28.83
- NUVARING (Drug) $25.64
- LILETTA (Drug) $23.25
- BRIXADI (Drug) $18.26
- TUDORZA PRESSAIR (Drug) $13.63
- Prenate Mini (Drug) $12.07
- BEXSERO (Biological) $11.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chicago
Dr. Bradley Torphy, M.d, M.D
Family Medicine — Payments: $1.3M
Family Medicine $1.3M
Dr. Sandy Gibson, D.o, D.O
Family Medicine — Payments: $252,793
Family Medicine $252,793
Igor Altman, D.o, D.O
Family Medicine — Payments: $127,185
Family Medicine $127,185
Ihab Aziz, Md, MD
Family Medicine — Payments: $65,230
Family Medicine $65,230
Dr. Abdulmassih Abdulmassih, M.d, M.D
Family Medicine — Payments: $28,980
Family Medicine $28,980
Dr. James Delis, D.o, D.O
Family Medicine — Payments: $28,724
Family Medicine $28,724